Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age
- Author
- Ego Seeman, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman (UGent) and Jean-Yves Reginster
- Organization
- Keywords
- BONE-MINERAL DENSITY, RANDOMIZED CLINICAL-TRIAL, LONG-TERM COMPLICATION, POSTMENOPAUSAL OSTEOPOROSIS, BISPHOSPHONATE TREATMENT, HIP FRACTURE, ALENDRONATE THERAPY, ANTIRESORPTIVE AGENTS, COST-EFFECTIVENESS, Clinical trial, ZOLEDRONIC ACID, Strontium Ranelate, Elderly population, Antiosteoporotic treatment, Osteoporosis, Osteoporotic fracture
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 2.11 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-1194250
- Chicago
- Seeman, Ego, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman, and Jean-Yves Reginster. 2010. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-years in Women over 80 Years of Age.” Bone 46 (4): 1038–1042.
- APA
- Seeman, E., Boonen, S., Borgstrom, F., Vellas, B., Aquino, J.-P., Semler, J., Benhamou, C.-L., et al. (2010). Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE, 46(4), 1038–1042.
- Vancouver
- 1.Seeman E, Boonen S, Borgstrom F, Vellas B, Aquino J-P, Semler J, et al. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE. 2010;46(4):1038–42.
- MLA
- Seeman, Ego, Steven Boonen, Frederik Borgstrom, et al. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-years in Women over 80 Years of Age.” BONE 46.4 (2010): 1038–1042. Print.
@article{1194250,
author = {Seeman, Ego and Boonen, Steven and Borgstrom, Frederik and Vellas, Bruno and Aquino, Jean-Pierre and Semler, Jutta and Benhamou, Claude-Laurent and Kaufman, Jean and Reginster, Jean-Yves},
issn = {8756-3282},
journal = {BONE},
keyword = {BONE-MINERAL DENSITY,RANDOMIZED CLINICAL-TRIAL,LONG-TERM COMPLICATION,POSTMENOPAUSAL OSTEOPOROSIS,BISPHOSPHONATE TREATMENT,HIP FRACTURE,ALENDRONATE THERAPY,ANTIRESORPTIVE AGENTS,COST-EFFECTIVENESS,Clinical trial,ZOLEDRONIC ACID,Strontium Ranelate,Elderly population,Antiosteoporotic treatment,Osteoporosis,Osteoporotic fracture},
language = {eng},
number = {4},
pages = {1038--1042},
title = {Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age},
url = {http://dx.doi.org/10.1016/j.bone.2009.12.006},
volume = {46},
year = {2010},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: